Stock GWLL GOLDENWELL BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Goldenwell Biotech, Inc.

Equities

GWLL

US38138N1046

Market Closed - OTC Markets
Other stock markets
 01:40:34 2023-12-13 pm EST 		5-day change 1st Jan Change
0.0586 USD -76.56% Intraday chart for Goldenwell Biotech, Inc. -.--% -.--%
Apr. 12 Goldenwell Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Goldenwell Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Goldenwell Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Goldenwell Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Goldenwell Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Goldenwell Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
GOLDENWELL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Goldenwell Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Goldenwell Biotech, Inc. Auditor Raises 'Going Concern' Doubt
CI
GOLDENWELL BIOTECH, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
AQ
GOLDENWELL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
Goldenwell Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Goldenwell Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
GOLDENWELL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
Goldenwell Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
GOLDENWELL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Goldenwell Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Goldenwell Biotech, Inc. Auditor Raises 'Going Concern' Doubt
CI
Goldenwell Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GWLL Stock
  4. News Goldenwell Biotech, Inc.